LIVZON PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

does not make any representation about the accuracy or completeness of this announcement and expressly disclaims any liability arising out of or in connection with all or any part of this announcement. We accept no liability for any loss caused by reliance on such content.

Overseas regulatory announcement

This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

This is to set forth the "Livzon Pharmaceutical Group Co., Ltd." published on the website of the Shenzhen Stock Exchange

Co., Ltd. Independent Director Nominee’s Statement and Commitment (Luo Huiyuan)” is for reference only.

By order of the board of directors

Livzon Pharmaceutical Group Co., Ltd. LivzonPharmaceuticalGroupInc.* company secretary

Liu Ning China, Zhuhai April 23, 2026

As of the date of this announcement, the executive director of the company is Mr. Tang Yanggang (vice chairman); the non-executive director of the company is Mr. Zhu Baoguo.

Sheng (Chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee director is Ms. Ran Yongmei; and the company’s independence is not The executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.

*Identification only

Securities code: 000513, 01513 Securities abbreviation: Livzon Group, Livzon Pharmaceutical Announcement number: 2026-31

Independent director nominee of Livzon Pharmaceutical Group Co., Ltd.

Statements and Commitments

Nominator: The Board of Directors of Livzon Pharmaceutical Group Co., Ltd. now nominates Luo Huiyuan

Candidate for independent director of the 12th Board of Directors of Livzon Pharmaceutical Group Co., Ltd.

Make a public statement. The nominee has agreed in writing to serve as the shareholder of Livzon Pharmaceutical Group

Independent Director Candidates for the 12th Board of Directors of the Company (see the Independent Director Candidates

Selection Statement). This nomination is based on a full understanding of the nominee’s occupation, education, professional title,

After detailed work experience, all part-time jobs, and whether there are any bad records such as major breach of trust, etc.

made, the nominator believes that the nominee complies with relevant laws, administrative regulations, departments

Regulations, normative documents and Shenzhen Stock Exchange business rules for independent director candidates

Requirements for qualifications and independence, specifically stating and committing to the following matters:

1. The nominee has passed the 11th session of Livzon Pharmaceutical Group Co., Ltd.

The nomination committee of the board of directors or the special meeting of independent directors will review the qualifications of the nominee and the nominee.

The nominator does not have any interests or other confidential information that may affect the independent performance of duties. Close relationship.

√ Yes □ No

If not, please explain in detail:

2. The nominee does not meet Article 170 of the Company Law of the People's Republic of China

Article 8 and other provisions prohibit the person from serving as a director of a company.

√ Yes □ No

If not, please explain in detail:

3. The nominee complies with the China Securities Regulatory Commission's "Administrative Measures for Independent Directors of Listed Companies"

and the qualifications and conditions for independent directors as stipulated in the business rules of the Shenzhen Stock Exchange.

√ Yes □ No

If not, please explain in detail:

4. The nominee meets the conditions for serving as an independent director as stipulated in the company's articles of association.

√ Yes □ No

If not, please explain in detail:

5. The nominee has participated in training and obtained relevant training recognized by the stock exchange. Training certification materials (if any).

√ Yes □ No

If not, please explain in detail:

6. The nominee's appointment as an independent director will not violate the "Official Affairs of the People's Republic of China" the relevant provisions of the Employees’ Law.

√ Yes □ No

If not, please explain in detail:

7. The nominee’s appointment as an independent director will not violate the Regulations of the Central Commission for Discipline Inspection of the Communist Party of China.

Fan Zhongguan cadres resign from public office or serve as managers of listed companies and funds after retirement (retirement) Notice of the Company’s Independent Directors and Independent Supervisors.

√ Yes □ No

If not, please explain in detail:

8. The nominee’s appointment as an independent director will not violate the provisions of the Organization Department of the Central Committee of the Communist Party of China.

Opinions on Further Regulating Party and Government Leading Cadres' Part-time Jobs in Enterprises" relevant regulations.

√ Yes □ No

If not, please explain in detail:

9. The nominee’s appointment as an independent director will not violate the regulations of the Central Commission for Discipline Inspection of the Communist Party of China, the Ministry of Education,

Relevant provisions of the Ministry of Supervision's "Opinions on Strengthening Anti-Corruption and Integrity Construction in Colleges and Universities".

√ Yes □ No

If not, please explain in detail:

10. The nominee’s appointment as an independent director will not violate the People’s Bank of China’s Joint Stock System Relevant provisions of "Guidelines on the Independent Director and External Supervisor System of Commercial Banks".

√ Yes □ No

If not, please explain in detail:

11. The nominee’s appointment as an independent director will not violate the Securities Fund Regulations of the China Securities Regulatory Commission.

Measures for the Supervision and Management of Directors, Supervisors, Senior Managers and Employees of Financial Operation Institutions" relevant regulations.

√ Yes □ No

If not, please explain in detail:

12. The nominee's appointment as an independent director will not violate the "Directors of Banking Financial Institutions"

The relevant provisions of the Measures for the Administration of Qualifications for Directors (Directors) and Senior Management Personnel.

√ Yes □ No

If not, please explain in detail:

13. The nominee’s appointment as an independent director will not violate the Regulations on Insurance Company Directors, Supervisors and

Regulations on the Administration of Qualifications of Senior Management Personnel" and "Measures on the Administration of Independent Directors of Insurance Institutions"

relevant regulations.

√ Yes □ No

If not, please explain in detail:

14. The nominee’s appointment as an independent director will not violate other laws, administrative regulations, Departmental regulations, normative documents and business rules of the Shenzhen Stock Exchange are important to independent directors.

Relevant regulations on job qualifications.

√ Yes □ No

If not, please explain in detail:

15. The nominee has basic knowledge related to the operation of listed companies and is familiar with relevant Relevant laws, administrative regulations, departmental rules, normative documents and Shenzhen Stock Exchange industry

business rules, with more than five years of legal, economic, management, accounting, financial or other experience

Work experience necessary to perform the duties of an independent director.

√ Yes □ No

If not, please explain in detail:

16. If nominated as an accounting professional, the nominee must have at least registration qualifications Qualifications as an accountant, or senior professional title or deputy title in accounting, auditing or financial management

Professor or above, doctoral degree, or senior professional title in economic management and in

More than five years of full-time work experience in professional positions such as accounting, auditing or financial management.

□ Yes □ No √ Not applicable

If not, please explain in detail:

17. The nominee, his immediate family members, and major social relations are not in the company or its affiliated companies.

√ Yes □ No

If not, please explain in detail:

18. The nominee and his immediate family members do not directly or indirectly hold the company

Shareholders with more than 1% of the issued shares are not natural persons among the top ten shareholders of the listed company.

East.

√ Yes □ No

If not, please explain in detail:

19. The nominee and his immediate family members no longer directly or indirectly hold the issued shares of the company.

He is not a shareholder holding more than 5% of the company's shares, nor is he a member of the top five shareholders of the listed company.

√ Yes □ No

If not, please explain in detail:

20. The nominee and his immediate family members are not the controlling shareholder or actual control of the company.

The person's affiliated enterprise holds office.

√ Yes □ No

If not, please explain in detail:

21. The nominee is not the company, its controlling shareholder, actual controller or or personnel who provide financial, legal, consulting, sponsorship and other services to their respective affiliated companies,

Including but not limited to all project team members and reviewers at all levels of intermediaries providing services

officers, persons who signed the report, partners, directors, senior managers and principal responsible persons

Responsible person.

√ Yes □ No

If not, please explain in detail:

22. The nominee has any relationship with the listed company and its controlling shareholders, actual controllers or

There are no significant business dealings with their respective subsidiaries, nor do they no longer have significant business dealings with each other.

The unit and its controlling shareholder and actual controller hold office.

√ Yes □ No

If not, please explain in detail:

23. The nominee does not have any of the items 17 to 2 in the last twelve months. Twelve items stipulate any situation.

√ Yes □ No

If not, please explain in detail:

24. Nominees who are not selected by the China Securities Regulatory Commission shall not hold office in listed companies. Directors and senior managers are prohibited from entering the securities market and the period has not yet expired

member.

√ Yes □ No

If not, please explain in detail:

25. The nominee has not been publicly determined by the securities exchange to be unfit to serve. Directors, senior managers, etc. of listed companies whose term has not yet expired.

√ Yes □ No

If not, please explain in detail:

26. The nominee has not been subject to any crime related to securities or futures in the past 36 months.

Persons subject to criminal punishment by judicial organs or administrative punishment by the China Securities Regulatory Commission.

√ Yes □ No

If not, please explain in detail:

27. The nominee is not suspected of securities and futures violations and has been certified by China.

The supervisory board has opened a case for investigation or the judicial authority has opened a case for investigation, but no clear conclusion has been reached

personnel.

√ Yes □ No

If not, please explain in detail:

28. The nominee has not been publicly disclosed by the stock exchange in the past 36 months. reprimand or report criticism three or more times.

√ Yes □ No

If not, please explain in detail:

29. The nominee has no bad records such as major breach of trust.

√ Yes □ No

If not, please explain in detail:

30. The nominee is not an independent director who failed to serve as an independent director for two consecutive times in the past.

Able to attend in person and not authorize other directors to attend board meetings and be recommended by the board of directors Please ask the shareholders' meeting to remove those who have been employed for less than twelve months.

√ Yes □ No

If not, please explain in detail:

31. Including the companies nominated this time, the nominees serve as independent directors. The number of domestic listed companies involved shall not exceed three.

√ Yes □ No

If not, please explain in detail:

32. The nominee has served as an independent director in the company for less than six consecutive years.

√ Yes □ No

If not, please explain in detail:

The nominator solemnly promises:

1. The nominator hereby guarantees that the above statement is true, accurate and complete, and there are no false records.

information, misleading statements or major omissions; otherwise, the nominator is willing to bear the consequences arising therefrom.

legal responsibilities and accept the self-regulatory measures or disciplinary sanctions of the Shenzhen Stock Exchange

points.

2. The nominator authorizes the secretary of the company’s board of directors to pass the contents of this statement through Shenzhen

The business area of the stock exchange is entered and reported to the Shenzhen Stock Exchange or announced to the outside world.

The above-mentioned actions of the secretary of the board of directors shall be regarded as the actions of the nominator, and the nominator shall be responsible for the relevant actions.

corresponding legal liability.

3. During the period when the nominee serves as an independent director, if the nominee fails to meet the independence requirements

and independent director qualifications, the nominator will report to the company's board of directors in a timely manner And urge the nominee to immediately resign as an independent director.

Nominator: Board of Directors of Livzon Pharmaceutical Group Co., Ltd. April 23, 2026